Denileukin Diftitox (Ontak) as Maintenance Therapy for Peripheral T-Cell Lymphomas: Three Cases with Sustained Remission
Peripheral T-cell lymphomas (PTCL) are rare but markedly aggressive forms of non-Hodgkin’s lymphoma (NHL). They carry a poor prognosis, with current therapeutic approach being generally ineffective. The most employed first-line treatment is CHOP (cyclophosphamide, doxorubicin, vincristine, and predn...
Saved in:
| Main Authors: | Alejandra C. Fuentes, Ellen Szwed, Cathy D. Spears, Sandeep Thaper, Long H. Dang, Nam H. Dang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Case Reports in Oncological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2015/123756 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast Cancer
by: William R. Gwin, et al.
Published: (2025-01-01) -
Spot OnTake-Home Points
by: Bryan S. Benn, MD, PhD, et al.
Published: (2025-03-01) -
Rapid Remission in Peripheral T-Cell Lymphoma of the Nasal Type by the Bortezomib plus CHOP Therapy
by: Li-Jun Xue, et al.
Published: (2010-01-01) -
Methotrexate and maintenance of remission in Crohn's disease
by: Martin Fishman
Published: (2001-01-01) -
Potential of nutraceutical products for irritable bowel syndrome remission maintenance
by: A. I. Ulyanin, et al.
Published: (2018-08-01)